Qina New Materials
Produces high-performance superalloy powders and wires for aerospace, gas turbines, and medical additive manufacturing.
- CEO / Founder
- Peng Weiping
- Team Size
- 201-500
- Stage
- Active
- Total Funding
- $75M
- Latest Round
- Strategic Investment
- Key Investors
- National Manufacturing Transformation and Upgrading Fund; AECC Investment Fund; Shenzhen Capital Group (SCGC); Walden International; Oriza Holdings; CITIC Securities Investment
Technology & Products
Key Products
High-temperature alloy master alloys; Special alloy wires for WAAM/DED; Spherical metal powders (Inconel, Hastelloy, Cobalt-Chrome); Hydrogen electrode nets; Non-noble metal catalysts
Technological Advantage
Controls the entire value chain from master alloy formulation to final powder/wire, ensuring superior batch-to-batch consistency and the ability to develop custom alloys 2x faster than pure atomization competitors.
Differentiation
Value Proposition
Reduces material-induced defects in critical aerospace components by providing high-purity (O/N/S ≤ 5ppm) metal feedstock with 99.9% chemical consistency and high fine-powder yields (>80%).
How They Differentiate
Qina maintains the highest domestic market share in AM superalloys by offering lower oxygen content (≤5ppm) and higher fine-powder yields compared to standard domestic providers, while being 30-40% more cost-effective than international imports.
Market & Competition
Target Customers
Aerospace engine manufacturers, gas turbine OEMs, medical implant producers, and 3D printing service bureaus.
Industry Verticals
Aerospace; Defense; Energy (Gas Turbines); Medical; Automotive (Turbocharging); Hydrogen Energy
Competitors
CISRI-Gaona; Avic-Melt; Western Superconducting; Sino-Euro Materials (SME); Carpenter Additive; Oerlikon AM
Growth & Milestones
Growth Metrics
Production value reached 310 million yuan ($43M USD) in 2025; 3,500 tons annual production capacity; 50% revenue CAGR over the last 3 years.
Major Milestones
2012: Company founded in Jiangsu; 2017: Pivoted to 3D printing materials as core growth driver; 2022: Completed Series B funding led by Walden International; 2024: Completed >200M RMB Series C led by AECC Fund; 2025: Secured strategic investment from the National Manufacturing Transformation and Upgrading Fund
Notable Customers
AECC (Aero Engine Corporation of China); COMAC; State Power Investment Corporation; Various Tier-1 Medical Implant Manufacturers